Eli Lilly’s Eloralintide Matches Zepbound’s Weight Loss in Mid-Stage Obesity Trial
A new weight-loss drug from Eli Lilly & Co. helped patients shed as much weight as popular shots like Zepbound, giving the company another edge in the fast-growing obesity market.
By Madison Muller · Bloomberg
A new weight-loss drug from Eli Lilly & Co. helped patients shed as much weight as popular shots like Zepbound, giving the company another edge in the fast-growing obesity market.